A syringe method for esophageal Lugol’s iodine chromoendoscopy

CC BY 4.0 · Endoscopy 2023; 55(S 01): E1256-E1257
DOI: 10.1055/a-2213-1316

E-Videos

Kai Liu

¹Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi’an, China (Ringgold ID: RIN66352)

,

Jiawei Bai

¹Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi’an, China (Ringgold ID: RIN66352)

,

Li Gao

¹Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi’an, China (Ringgold ID: RIN66352)

,

Xin Dong

¹Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi’an, China (Ringgold ID: RIN66352)

,

Ying Han

¹Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi’an, China (Ringgold ID: RIN66352)

,

Zhiguo Liu

¹Xijing Hospital of Digestive Diseases, Air Force Medical University (Fourth Military Medical University), Xi’an, China (Ringgold ID: RIN66352)

References
1 Liu M, Zhou R, Guo C. et al. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus. Gastrointest Endosc 2021; 93: 1065-1073.e3
2 Guo Q, Fan X, Zhu S. et al. Comparing N-acetylcysteine with sodium thiosulfate for relieving symptoms caused by Lugol’s iodine chromoendoscopy: a randomized, double-blind trial. Gastrointest Endosc 2022; 95: 249-257
3 Gotoda T, Kanzaki H, Okamoto Y. et al. Tolerability and efficacy of the concentration of iodine solution during esophageal chromoendoscopy: a double-blind randomized controlled trial. Gastrointest Endosc 2020; 91: 763-770